Voglibose is an oral antidiabetic medication primarily used to manage post-meal (postprandial) blood sugar levels in patients with Type 2 Diabetes Mellitus. It belongs to a class of drugs known as alpha-glucosidase inhibitors, which help delay the digestion and absorption of carbohydrates in the small intestine. This action results in a gradual rise in blood sugar levels and helps reduce the risk of long-term complications associated with diabetes.
What is Voglibose?
Voglibose is a prescription medication used to lower postprandial blood glucose levels in Type 2 diabetes patients. It is not an insulin or sulfonylurea agent but works by inhibiting enzymes responsible for breaking down complex carbohydrates into glucose. It is especially useful for individuals who experience spikes in blood sugar after meals.
What are the Uses of Voglibose Tablets?
Voglibose is primarily used to manage post-meal blood sugar spikes in people with type 2 diabetes. It helps improve glycemic control by slowing down the digestion and absorption of carbohydrates in the small intestine.
Voglibose is commonly used to
Control post-meal blood glucose levels.
Improve glycemic control when diet, exercise, or other antidiabetic medications are insufficient.
Delay the progression of diabetes-related complications, especially macrovascular risks.
Manage blood sugar without causing hypoglycemia when used alone.
Conditions Voglibose Treats
Type 2 Diabetes Mellitus (as monotherapy or in combination with other antidiabetic agents)
Postprandial hyperglycemia (spike in blood sugar after meals)
Secondary Uses of Voglibose
Sometimes used off-label in prediabetic patients to prevent disease progression
Combined with other medications in complex diabetes management plans
How Does Voglibose Tablet Work?
Voglibose tablet works by inhibiting the alpha-glucosidase enzymes in the small intestine. These enzymes are responsible for breaking down carbohydrates into glucose. By slowing this process:
The absorption of sugar into the bloodstream is delayed.
Sudden spikes in blood glucose after meals are minimised.
Blood sugar remains more stable throughout the day.
This mechanism helps improve overall glycemic control without increasing insulin secretion.
Voglibose Dosage Instructions
Voglibose is an oral antidiabetic medication primarily used to manage postprandial (after-meal) blood sugar levels in people with type 2 diabetes. It is available in the following dosage forms:
Dosage Form
Strengths Available
Route
Common Use
Tablet
0.2 mg, 0.3 mg
Oral
Used to control post-meal blood glucose in type 2 diabetes
For patients requiring multiple antidiabetic agents in a single pill
The dosage of Voglibose is determined by your doctor based on your individual condition and response to treatment. It is typically taken just before meals to effectively control blood sugar after eating.
Typical Adult Dosage
0.2 mg taken orally three times daily, just before meals.
Dose may be adjusted based on the patient's response and the severity of diabetes.
Always follow your doctor's instructions regarding dosage.
What Should I Do If I Miss a Dose?
Take the missed dose as soon as you remember before your next meal.
If it's close to your next scheduled dose, skip the missed dose.
Do not take two doses at once, as this may increase the risk of side effects.
What Happens if I Overdose?
Overdosing on Voglibose may lead to:
Excessive flatulence
Diarrhea
Abdominal pain
Hypoglycemia (especially if combined with other antidiabetics)
Seek medical attention immediately in case of an overdose.
Get a second opinion from trusted experts and makeconfident, informed decisions.
Common side effects of Voglibose include flatulence, abdominal bloating, and mild diarrhea. These effects are usually temporary and may subside as your body adjusts to the medication.
Common Side Effects
Flatulence
Diarrhea
Nausea
Abdominal pain
Dizziness
Skin rash
Serious or Rare Side Effects
Pneumatosis intestinalis (gas cysts in the bowel wall)
Abnormal liver function tests
Vomiting
Most side effects are mild and subside over time. Contact a doctor if symptoms are severe or persistent.
Precautions for Voglibose
Patients with gastrointestinal disorders, kidney or liver problems, or a history of bowel obstruction should use Voglibose with caution. It is also not recommended during pregnancy or breastfeeding unless advised by a doctor.
Pregnant or breastfeeding women (unless advised by a doctor)
Use With Caution In
Patients with diabetes-related ketoacidosis
People with a history of gastrointestinal surgery or disorders
Are There Any Age Restrictions for Using Voglibose?
Voglibose tablets are typically prescribed for adult patients with type 2 diabetes to manage post-meal blood sugar levels. Its use in children and adolescents is not recommended, as sufficient clinical studies have not been conducted to confirm its safety and effectiveness in these age groups. Always follow your doctor's advice before use.
Alcohol or Food Interactions
No known interaction with alcohol, but alcohol may worsen blood glucose control.
Take with meals for best results and to avoid gastrointestinal issues.
Possible Interactions with Other Medications
Voglibose may interact with other antidiabetic medications, leading to a higher risk of low blood sugar. It's important to inform your doctor about all medications or supplements you are taking.
Voglibose can interact with other antidiabetic medications, such as:
Insulin or sulfonylureas may increase the risk of hypoglycemia
Digestive enzyme supplements may reduce Voglibose's effectiveness
Antacids or drugs that affect the gastrointestinal tract may alter absorption
Always inform your doctor of all medications, supplements, or herbal remedies you are taking.
How Should Voglibose Be Stored?
Store Voglibose tablets at room temperature, away from direct sunlight, moisture, and heat. Keep the medication out of reach of children and pets to ensure safety.
Store at room temperature (20°C to 25°C / 68°F to 77°F)
Keep away from moisture, heat, and direct sunlight
Keep in the original packaging to protect from air exposure
Keep out of reach of children
What Happens If Voglibose Is Not Stored Properly?
Improper storage may lead to reduced effectiveness or degradation of the drug.
Voglibose vs Sitagliptin
Voglibose
Sitagliptin
Voglibose is an alpha-glucosidase inhibitor that is used to treat diabetes mellitus by lowering post-prandial blood glucose levels.
Sitagliptin is a prescription drug, and it is available in the form of an oral tablet.
Voglibose 0.2 MG Tablet is used to help patients with Type 2 Diabetes Mellitus lower their blood glucose levels, particularly when other medications aren't working.
Sitagliptin tablets can be taken with a proper diet, exercise, and other medications for controlling high blood sugar.
The maximum recommended daily dose of Voglibose is typically 0.6 mg, taken as 0.2 mg three times a day before meals. Always follow your doctor’s prescription, as dosage may vary based on individual needs.
No, voglibose and metformin are not the same. Voglibose is an alpha-glucosidase inhibitor that slows down carbohydrate absorption, while metformin is a biguanide that decreases glucose production in the liver and improves insulin sensitivity.
Voglibose is generally considered safe for the kidneys, but it should be used with caution in patients with renal impairment. Always consult a healthcare provider before using voglibose if you have kidney issues.
Both acarbose and voglibose are alpha-glucosidase inhibitors used to control postprandial blood sugar levels in type 2 diabetes. The main difference lies in their chemical structure and potency. Acarbose is more commonly associated with gastrointestinal side effects like flatulence and diarrhea, whereas voglibose is considered to have a slightly different side effect profile and is often preferred for its tolerability.
Voglibose can cause gastrointestinal side effects, including constipation, though it is less common compared to other side effects like flatulence and abdominal discomfort.
The best time to take voglibose is just before meals. This allows the medication to effectively inhibit the enzymes that break down carbohydrates, thereby reducing postprandial blood sugar spikes.
Voglibose is effective in reducing postprandial hyperglycemia and can be an important part of the management of type 2 diabetes when used in combination with diet, exercise, and other antidiabetic medications. Its effectiveness can vary among individuals.
Voglibose is not typically associated with weight gain. It primarily affects carbohydrate absorption and does not directly influence weight.
Yes, voglibose can cause gastrointestinal side effects, including gas (flatulence), due to its mechanism of slowing carbohydrate absorption in the intestines.
Voglibose is primarily used for type 2 diabetes to manage postprandial hyperglycemia. It is not typically used in type 1 diabetes, where insulin therapy is the mainstay of treatment. Always consult a healthcare provider for appropriate diabetes management.
Disclaimer: The information provided is accurate and up-to-date to the best of our knowledge. However, it should not be considered a substitute for medical advice or consultation. We do not guarantee its completeness or accuracy. The absence of specific warnings does not mean a medicine is safe for all users. We are not responsible for any outcomes based on this information and strongly recommend consulting a doctor for any medical concerns or questions.
040 68334455
WhatsApp
Patient Portal
Home Care
